Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
CompletedNot applicableNCT02580734
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine whether melatonin is effective in the treatment of burning mouth syndrome (BMS).
Study details
- Official title
- Melatonin to Treat Burning Mouth Syndrome (BMS): A Randomized, Cross-over, Placebo-controlled, Triple-blind Clinical Trial
- Conditions
- Burning Mouth Syndrome
- Interventions
- Dietary supplement: melatonin
- Sponsor
- University of Milan
- Start date
- 2014-03
- Primary completion
- 2015-05
- Sex
- All
- Age range
- from 18 Years to 90 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients over 18 yrs suffering from burning mouth syndrome Exclusion Criteria: * epilepsy * pregnancy * concomitant treatment with melatonin * concomitant anticoagulants * night time working persons
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02580734